177 related articles for article (PubMed ID: 28478995)
21. A conditioned response as a measure of impulsive-compulsive behaviours in Parkinson's disease.
Evans AH; Kettlewell J; McGregor S; Kotschet K; Griffiths RI; Horne M
PLoS One; 2014; 9(2):e89319. PubMed ID: 24586685
[TBL] [Abstract][Full Text] [Related]
22. Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.
Claassen DO; van den Wildenberg WP; Harrison MB; van Wouwe NC; Kanoff K; Neimat JS; Wylie SA
Pharmacol Biochem Behav; 2015 Feb; 129():19-25. PubMed ID: 25459105
[TBL] [Abstract][Full Text] [Related]
23. Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease.
Djamshidian A; Jha A; O'Sullivan SS; Silveira-Moriyama L; Jacobson C; Brown P; Lees A; Averbeck BB
Mov Disord; 2010 Oct; 25(13):2203-10. PubMed ID: 20721918
[TBL] [Abstract][Full Text] [Related]
24. Dopamine agonists and the suppression of impulsive motor actions in Parkinson disease.
Wylie SA; Claassen DO; Huizenga HM; Schewel KD; Ridderinkhof KR; Bashore TR; van den Wildenberg WP
J Cogn Neurosci; 2012 Aug; 24(8):1709-24. PubMed ID: 22571461
[TBL] [Abstract][Full Text] [Related]
25. Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson's disease, atypical Parkinsonian disorders and non-Parkinsonian populations.
Maloney EM; Djamshidian A; O'Sullivan SS
J Neurol Sci; 2017 Mar; 374():47-52. PubMed ID: 28108021
[TBL] [Abstract][Full Text] [Related]
26. Alexithymia-an independent risk factor for impulsive-compulsive disorders in Parkinson's disease.
Goerlich-Dobre KS; Probst C; Winter L; Witt K; Deuschl G; Möller B; van Eimeren T
Mov Disord; 2014 Feb; 29(2):214-20. PubMed ID: 24123483
[TBL] [Abstract][Full Text] [Related]
27. Stroop test performance in impulsive and non impulsive patients with Parkinson's disease.
Djamshidian A; O'Sullivan SS; Lees A; Averbeck BB
Parkinsonism Relat Disord; 2011 Mar; 17(3):212-4. PubMed ID: 21247790
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
Michely J; Barbe MT; Hoffstaedter F; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
Neuropsychologia; 2012 Aug; 50(10):2506-14. PubMed ID: 22776611
[TBL] [Abstract][Full Text] [Related]
29. Evolution of impulsive-compulsive behaviors and cognition in Parkinson's disease.
Erga AH; Alves G; Tysnes OB; Pedersen KF
J Neurol; 2020 Jan; 267(1):259-266. PubMed ID: 31628533
[TBL] [Abstract][Full Text] [Related]
30. Are there ethnic differences in impulsive/compulsive behaviors in Parkinson's disease?
Chiang HL; Huang YS; Chen ST; Wu YR
Eur J Neurol; 2012 Mar; 19(3):494-500. PubMed ID: 22040282
[TBL] [Abstract][Full Text] [Related]
31. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
[TBL] [Abstract][Full Text] [Related]
32. Role of habenula and amygdala dysfunction in Parkinson disease patients with punding.
Markovic V; Agosta F; Canu E; Inuggi A; Petrovic I; Stankovic I; Imperiale F; Stojkovic T; Kostic VS; Filippi M
Neurology; 2017 Jun; 88(23):2207-2215. PubMed ID: 28490656
[TBL] [Abstract][Full Text] [Related]
33. Impulsive and compulsive behaviors among Danish patients with Parkinson's disease: prevalence, depression, and personality.
Callesen MB; Weintraub D; Damholdt MF; Møller A
Parkinsonism Relat Disord; 2014 Jan; 20(1):22-6. PubMed ID: 24090948
[TBL] [Abstract][Full Text] [Related]
34. A multidimensional approach to impulsivity in Parkinson's disease: measurement and structural invariance of the UPPS Impulsive Behaviour Scale.
Bayard S; Joly E; Ghisletta P; Rossignol A; Herades Y; Geny C; Gély-Nargeot MC; Rochat L
Psychol Med; 2016 Oct; 46(14):2931-2941. PubMed ID: 27460484
[TBL] [Abstract][Full Text] [Related]
35. Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?
Djamshidian A; O'Sullivan SS; Sanotsky Y; Sharman S; Matviyenko Y; Foltynie T; Michalczuk R; Aviles-Olmos I; Fedoryshyn L; Doherty KM; Filts Y; Selikhova M; Bowden-Jones H; Joyce E; Lees AJ; Averbeck BB
Mov Disord; 2012 Aug; 27(9):1137-45. PubMed ID: 22821557
[TBL] [Abstract][Full Text] [Related]
36. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
Bayard S; Cochen De Cock V; Dauvillers Y
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
[TBL] [Abstract][Full Text] [Related]
37. Impulsive oculomotor action selection in Parkinson's disease.
Duprez J; Houvenaghel JF; Argaud S; Naudet F; Robert G; Drapier D; Vérin M; Sauleau P
Neuropsychologia; 2017 Jan; 95():250-258. PubMed ID: 28039058
[TBL] [Abstract][Full Text] [Related]
38. Personality Traits and Cortical Activity Affect Gambling Behavior in Parkinson's Disease.
Balconi M; Siri C; Meucci N; Pezzoli G; Angioletti L
J Parkinsons Dis; 2018; 8(2):341-352. PubMed ID: 29614700
[TBL] [Abstract][Full Text] [Related]
39. Risky decision-making and affective features of impulse control disorders in Parkinson's disease.
Martini A; Ellis SJ; Grange JA; Tamburin S; Dal Lago D; Vianello G; Edelstyn NMJ
J Neural Transm (Vienna); 2018 Feb; 125(2):131-143. PubMed ID: 29119257
[TBL] [Abstract][Full Text] [Related]
40. The relationship between impulsivity and impulse control disorders in Parkinson's disease.
Isaias IU; Siri C; Cilia R; De Gaspari D; Pezzoli G; Antonini A
Mov Disord; 2008 Feb; 23(3):411-5. PubMed ID: 18067187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
